av永久免费网站在线观看丨果冻传媒av精品一区丨成人毛片网丨伊人88丨久久久久青草线蕉综合丨三级三级18女男丨九九天堂网丨亚洲日韩av无码丨各种少妇正面bbw撒尿丨91香蕉在线看丨av免费在线不卡丨www夜色丨国产精品爽丨欧美巨大极度另类丨97色伦图片97综合影院丨欧美日韩国产高清丨av网址在线免费观看丨国产成人精选在线观看不卡丨免费成人精品丨中文字幕在线一区丨www91麻豆丨国产成人精品午夜二三区波多野丨91国在线啪丨在线性视频丨国产第一毛片

Output value of biomedical industry in SIP reaches RMB 90 billion in 2019

SIP started deployment for biomedical industry in 2007. Since then, the industry has maintained an annual growth of more than 20% in total output value, which reached RMB 90 billion last year. This has enabled SIP to rank among the country’s best clusters of biomedicine businesses. Statistics show that SIP recorded a long list of new drugs that received approvals last year for clinical trials, which account for 10% of the national total, and of them, new biological drugs developed in SIP accounted for 20% of the national total.[MORE]